P1086 / Phase II Study in HIV Positive Pregnant Women to Assess the Safety and Immunogen

P1086 was a multi-center, Phase II, open label study of an inactivated Influenza A (H1N1) 2009 monovalent vaccine.  The study was designed to determine the safety and antibody response after each of two doses of Influenza A (H1N1) 2009 Monovalent Vaccine in HIV-1 infected pregnant women.